« Back
Home /
DCZ0415

DCZ0415

Item no.	DCC-DC28670-100mg
Manufacturer	DCChemicals
CASRN	2242470-43-3
Amount	100 mg
Quantity options	100 mg 1 g 250 mg
Category	In Vivo
Applications	other, IV
Specific against	other
Smiles	O=C1C2([H])C([H])(C(N1C1C([H])=C([H])C(C([H])([H])C3C([H])=C([H])N=C([H])C=3[H])=C([H])C=1[H])=O)C1([H])C([H])=C([H])C2([H])C2([H])C([H])([H])C21[H]
Available
Manufacturer - Applications	DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients.
Molecular Weight	356, 4171

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time